*Logical vs. Emotional Truths on the JACC Cardiovascular Intervention Study*

(1/14)

Let me summarize below...

From @JACCJournals

jacc.org/doi/10.1016/j.…
(2/14)

Aims:

The study used the NCDR CathPCI registry to examine

a.The proportion of patients who met the inclusion criteria for ischemia (versus 4 other groups that did not meet the Ischemia-trial criteria).

b.The association between each group with all-cause mortality
(3/14)

Methods:

Patients in the CathPCI registry were categorized into:

1 ACS + Arrest + Cardiogenic Shock (n=538K)
2 Not Ischemia High Risk (n=71K)
3 Not Ischemia (low risk) (n=67K)
4 ***ISCHEMIA-like (n=125k) +stress OR abnormal FFR***
5 Not classified (n=123k)
(4/14)

Results:

Ischemia-like cohort:

Mean age = 67 years
Female patients = 26%
Mostly non-Hispanic Whites
DM = 41%
Highest #RadialFirst utilization = 53%
(5/14) Mortality Rate

Ischemia-like (n=125k) had the lowest mortality: 0.11%
Ischemia-Like: 135 patients out of 124,302 = 0.00108
-
Not Ischemia High-Risk: 481 out of 71,852= 0.00669
Not-Ischemia Low-Risk: 114 out of 67,159 = 0.00169
Not classified: 289 out of 123,899 = 0.00233
(6/14)

Of ALL patients who underwent PCI from 2017 to 2019 | only 13% resemble the ischemia trial population.

(125,302/927,011=13%)
(7/14)

The calculation of this proportion (%) above in (6/14) is what the trialists question.

See 8, 9 and 10 below.
(8/14)

Trialists' Take #1:

Those who have low risk features should not be included in the denominator because they do not benefit from PCI | given data from courage and BARI 2D
(9/14)

Trialists' Take 2:

Those who are not classified (because they do not have stress test reported in NCDR) may included in the ischemia-like cohort if the data was available ~ 50%.
(10/14)

Fair questioning by the trialists, but these are assumptions that cannot be proven and reflected by data.

** I also did not include the discussion on ischemia-CKD study inclusion (slicing the denominator and numerator further).
(11/14)

The trialists' conclusion in the editorial was fair and balanced:

No one knows exactly what the % of Ischemia-population is in practice.

that said...
(12/14)

The principal investigator(s) of JACC Interv Study @jaygirimd are not expected to introduce assumptions when reporting NCDR data from clinical practice.

They tried to estimate the % of patients who most resemble ischemia based on available data..
(13/14)

My take:

1. In the United States, most PCI is performed for ACS (not ischemia like patients)

2. Ischemia criteria when applied to clinical practice is clearly not a majority.

3. The mortality rate with PCI in Ischemia like population is exceedingly small!

Fair?
(14/14)

Good study; good question; good editorial!

Truth is grounded in ethics.

We should distinguish between emotional truths and logical truths!

#cardiotwitter
*be
*were

Sorry!

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Abdulla A. Damluji, MD, PhD | 🏊🏻‍♂️🚴🏻‍♂️🏃🏻

Abdulla A. Damluji, MD, PhD | 🏊🏻‍♂️🚴🏻‍♂️🏃🏻 Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @DrDamluji

5 Nov
SURTAVI

No differences in death ,stroke, MI, or HF between TAVR and Surgery during longer follow-up

#TCT2021 ImageImageImageImage
Hemodynamics

Total AR and PVL

KCCQ no difference after 1 year

NYHA class at one year 1 ImageImageImageImage
Summary for SURTAVI

Self expanding valve

#TCT2021 Image
Read 12 tweets
5 Nov
Cardiac Arrest and Cardiogenic Shock

There is a societal paper on this in the works too!

Very important work!

@Babar_Basir @venumenon10

#TCT2021 @TCTMD ImageImageImageImage
Methylprednisone - ? not helpful

Advanced reperfusion strategies - small trial

#TCT2021 ImageImage
SCAI Shock Classification

Milrinone vs Dobutamine - no difference

Gaps in pressers in CICU setting: pressers and antiplatelets

@seanvandiepen @JasonKatzMD

#TCT2021 ImageImageImageImage
Read 19 tweets
5 Nov
The use of LV venting to prevent LV thrombus!

#TCT2021 Image
Cardiogenic shock data: excellent presentation by @thiele_holger @HenrytTimothy

#TCT2021 ImageImage
Outcomes in registries = @InovaHealth is up there :)

NCSI data.

@Babar_Basir @BillONeillMD ImageImageImageImage
Read 6 tweets
4 Nov
iFR vs FFR guided coronary Revascularization

iFR-Swedeheart 5 year outcomes

iFR vs FFR (randomized registry)

Study population: stable, unstable angina and NSTEMI

No loss to follow-up

#TCT2021 ImageImageImageImage
Results ImageImageImageImage
No difference between iFR and FFR ImageImageImageImage
Read 4 tweets
4 Nov
Radiance-HTN TRIO (investigative device)

Renal denervation

Elevated BP on 3 anti-hypertensives

Randomized (blinded)

Renal denervation vs sham

Follow-up for 6 months

Outcome BP and medication burden

#TCT2021 ImageImageImage
Tough design ImageImage
Med adherence Image
Read 6 tweets
4 Nov
EROSION III

OCT vs angiography

Study population: STEMI

Randomized 1:1

Outcomes MACCE at 1 month and 1 year

#TCT2021 ImageImageImageImage
Results ImageImageImageImage
Secondary endpoint and procedural data ImageImageImageImage
Read 5 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(